Grants for Independent school districts - Health

This grant provides funding to nonprofit organizations, food pantries, schools, and farmers markets in Columbia County, New York, to improve access to fresh and healthy food for low-income households and address food insecurity.

This funding opportunity supports collaborative clinical studies on mental illness across multiple research sites, encouraging diverse participation and innovative research into genetics, biomarkers, and treatment responses.

This Notice of Intent to Publish is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects for the following Notice of Funding Opportunity (NOFO), which is expected to be published in January 2024, with an anticipatedapplication receipt date in May 2024. The Brain Research through Advancing Innovative Neurotechnologies(BRAIN) Initiative intends to promote a new initiative by publishing a NOFO to solicit applications that would support development and preclinical testing, beginning withproof of concept,of next-generation recording and/or modulation devices for human use to further our understanding of the human central nervous system and treat nervous system disorders. This NOFO will utilize the R18 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides financial support to organizations that aim to improve services for older adults with behavioral health issues in senior nutrition programs, focusing on creating accessible and culturally sensitive practices.

This funding opportunity invites researchers to develop and apply advanced imaging techniques to better understand the role of inflammation in cancer, fostering collaboration between cancer scientists and imaging experts.

This funding opportunity supports research training for underrepresented students and health professionals in cardiovascular, pulmonary, hematologic diseases, and sleep disorders, aiming to increase diversity in the biomedical research workforce and reduce health disparities.

This Funding Opportunity Announcement (FOA) allows for renewal and competitive revision applications, and their resubmissions, for funded U24?Research Resource/Infrastructure?applications?that?support?large-scale, complex research programs focused on?Alzheimers disease (AD) and?Alzheimers disease-related dementias (ADRD).?It is anticipated that such programs will likely involve a team of investigators within a single institution or a consortium of?institutions?and?align with one or more?AD/ADRD implementation research milestones?supporting the?research goals of the??National Plan to Address Alzheimers and Related Dementias.

The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1. Phenotypes associated with addictive behaviors and/or vulnerability to distinct stages along the substance use disorder (SUD) trajectory (e.g. initial/acute use, escalation of use, acquisition of tolerance, dependence, uncontrolled use, abstinence and relapse or recovery); 2. Behaviors associated with SUD (e.g. impulsivity, novelty seeking, delayed discounting, and other genetically-associated phenotypes); and 3. Comorbidities that demonstrate genetic correlations with phenotypes and behaviors linked with SUD (e.g. anxiety, stress, poor maternal care, social defeat, and other paradigms). Applications may examine any type of variant, including single nucleotide variants (SNVs), indels, large and small structural variants, and all types of mobile DNA. NIDA encourages applications that take genomics, multi-omics, and/or data-based approaches that integrate multi-level omics data, delineate gene networks, and/or uncover the function of known or newly discovered genetic or epigenetic variants. NIDA expects these studies to uncover novel mechanisms that contribute to SUD and facilitate the discovery of targets for intervention and guide the development of individualized therapeutics to treat these different aspects of SUD.

This funding opportunity provides financial support for research and evaluation projects aimed at improving malaria control and prevention strategies in Kenya, specifically targeting collaborations with local health institutions.

This funding opportunity provides financial support to early-career researchers who have received specific NIAMS awards, enabling them to conduct small-scale studies and gather data to advance their research and secure future funding.

This funding opportunity supports Anne Arundel County Public School clubs and youth organizations in implementing peer-led education programs focused on preventing substance misuse among youth.

This funding initiative provides $20,000 each to ten nonprofit organizations and community groups in the U.S. to transform vacant lots into community gardens that promote health, engagement, and compassion in under-resourced areas.

This funding opportunity supports research to develop and test behavioral interventions aimed at reducing sexual risk behaviors and increasing the use of HIV prevention methods among HIV-negative Black and Hispanic men who have sex with men and use substances before or during sex.

This funding opportunity provides support for the development and management of early-phase cancer prevention clinical trials, focusing on evaluating interventions to reduce cancer risk across various organ sites.

The "Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research" grant aims to fund exploratory research projects that focus on improving the quality of cancer samples through the development and validation of innovative technologies, which will help in preserving sample integrity, establishing quality control, and reducing variations in sample quality, ultimately enhancing cancer research, diagnosis, and treatment.

This funding opportunity provides financial support for organizations to conduct research on telehealth services, particularly focusing on improving access and addressing disparities for underserved populations in the United States.

The Connecticut Grown for Connecticut Kids (CTG4CTK) Grant Program is designed to provide financial assistance to various educational and childcare entities within Connecticut to foster the development of farm-to-school programs. Administered by the Connecticut Department of Agriculture, this grant aligns with a broader mission to enhance the state's economy, improve child health, and enrich the educational experiences of students through connections with local agriculture. The program's core objective is to build capacity for long-term Farm to School Programs, emphasizing the integration of local foods into child nutrition programs and promoting hands-on learning about nutrition and farm-to-school connections. The target beneficiaries of the CTG4CTK Grant include local or regional boards of education, regional educational service centers, cooperative arrangements, child care centers, group child care homes, family child care homes, and any organization or entity involved in developing farm-to-school programs, including Connecticut farmers. The impact goals are multi-faceted: increasing the availability of local foods in child nutrition programs, enabling educators to use experiential learning to teach about nutrition and agricultural connections, sustaining relationships with local farmers and producers, enriching students' educational experiences, improving the health of children in the state, and boosting the state's economy. The grant program prioritizes applicants located in alliance districts or those providing school readiness programs. Another key focus is to fund applicants who can demonstrate a broad commitment from various stakeholders, including school administrators, school nutrition professionals, educators, and community members. Applicants are specifically requested to detail the support for their projects and how input was gathered during the idea formulation. This emphasis ensures that funded programs have strong community backing and are well-conceived. The CTG4CTK Grant offers several tracks, including Farm to School (K-12) Local Procurement Assistance, Farm to School (K-12) Experiential Learning, Producer Capacity Building, Farm to Early Care and Education (ECE), and a one-time Shipping Container Growing Grant. While the general grant size ranges from $10,000 to $100,000, the maximum award for Tracks 1, 2, and 4 is $75,000, with a higher cap of $250,000 for the Shipping Container Growing grant. The project period for all grants is 24 months. The expected outcomes include a greater integration of local foods, enhanced nutritional education, strengthened local agricultural ties, and overall improvements in child well-being and the state's economic vitality.

This funding opportunity supports researchers in conducting single-site clinical trials focused on heart, lung, and blood health, encouraging innovative trial designs and community engagement.

The "HEAL Initiative: Understanding Individual Differences in Human Pain Conditions" grant aims to fund research that explores the differences in how individuals experience pain, with the goal of improving personalized pain treatment strategies and understanding the impact of factors like additional health conditions or substance use.

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance. The goal of this initiative is to support research aimed at (1) identification of targets and pathways by which transcriptional activity of HIV can be suppressed in HIV reservoirs including the CNS in people with SUD, and (2) application of emerging small molecule drug discovery approaches to identify novel compounds that can be utilized as pharmacological probes and as drugs to suppress HIV transcription in people with HIV-SUD comorbidity.